131 related articles for article (PubMed ID: 875219)
21. Mitochondrial damage produced by estradiol valerate in the Dunning (R3327H) rat prostatic adenocarcinoma: a preliminary report.
Arcadi JA; Poolsawat S
Prog Clin Biol Res; 1981; 75B():329-34. PubMed ID: 7323100
[No Abstract] [Full Text] [Related]
22. A stroma targeted therapy enhances castration effects in a transplantable rat prostate cancer model.
Johansson A; Jones J; Pietras K; Kilter S; Skytt A; Rudolfsson SH; Bergh A
Prostate; 2007 Nov; 67(15):1664-76. PubMed ID: 17854058
[TBL] [Abstract][Full Text] [Related]
23. The relationship of androgen receptor levels to androgen responsiveness in the Dunning R3327 rat prostate tumor sublines.
Diamond DA; Barrack ER
J Urol; 1984 Oct; 132(4):821-7. PubMed ID: 6471235
[TBL] [Abstract][Full Text] [Related]
24. Proliferative response of the Dunning R3327H experimental model of prostatic adenocarcinoma to conditions of androgen depletion and repletion.
English HF; Kloszewski ED; Valentine EG; Santen RJ
Cancer Res; 1986 Feb; 46(2):839-44. PubMed ID: 3940646
[TBL] [Abstract][Full Text] [Related]
25. Castration induces apoptosis in the ventral prostate but not in an androgen-sensitive prostatic adenocarcinoma in the rat.
Brändström A; Westin P; Bergh A; Cajander S; Damber JE
Cancer Res; 1994 Jul; 54(13):3594-601. PubMed ID: 8012987
[TBL] [Abstract][Full Text] [Related]
26. Purification and characterization of acid phosphatase from Dunning R3327H prostatic adenocarcinoma.
Lee C; Murphy GP; Chu TM
Cancer Res; 1980 Apr; 40(4):1245-8. PubMed ID: 7357554
[TBL] [Abstract][Full Text] [Related]
27. Approaches to prostatic cancer chemotherapy using the Dunning R3327H prostatic adenocarcinoma.
Padilla GM; Petrow V; Marts SA; Mukherji S
Prostate; 1985; 6(2):129-43. PubMed ID: 3975175
[TBL] [Abstract][Full Text] [Related]
28. A rat prostatic adenocarcinoma as a model for the human disease.
Müntzing J; Kirdani RY; Murphy GP; Sandberg AA
Invest Urol; 1979 Jul; 17(1):37-41. PubMed ID: 447485
[TBL] [Abstract][Full Text] [Related]
29. The timing of androgen ablation therapy and/or chemotherapy in the treatment of prostatic cancer.
Isaacs JT
Prostate; 1984; 5(1):1-17. PubMed ID: 6694914
[TBL] [Abstract][Full Text] [Related]
30. Investigation of different combinations of estrogen therapy and radiation therapy on prostatic adenocarcinoma (R-3327).
Camuzzi F; Block NL; Stover B; Gottlieb C; Charyulu K; Politano VA
Urology; 1980 May; 15(5):443-7. PubMed ID: 7052707
[TBL] [Abstract][Full Text] [Related]
31. Nb rat prostate adenocarcinoma model androgen-sensitive tumor: metastasis control.
Drago JR; Weed P; Fralisch A
J Surg Oncol; 1983 Sep; 24(1):33-5. PubMed ID: 6887934
[TBL] [Abstract][Full Text] [Related]
32. An animal model for the study of prostate carcinoma.
Lubaroff DM; Canfield L; Rasmussen GT; Reynolds CW
Natl Cancer Inst Monogr; 1978 Dec; (49):275-81. PubMed ID: 748781
[TBL] [Abstract][Full Text] [Related]
33. After radiotherapy testosterone stimulation is unable to increase growth in the dunning R3327-PAP prostate tumour.
Granfors T; Tomic R; Bergh A; Rydh M; Löfroth PO; Widmark A
Urol Res; 1999 Oct; 27(5):357-61. PubMed ID: 10550524
[TBL] [Abstract][Full Text] [Related]
34. Biological effects of hormonal treatment regimens on a transplantable human prostatic tumor line (PC-82).
van Steenbrugge GJ; Groen M; Romijn JC; Schröder FH
J Urol; 1984 Apr; 131(4):812-7. PubMed ID: 6708205
[TBL] [Abstract][Full Text] [Related]
35. Growth characteristics and immunogenicity of the R-3327 rat prostate carcinoma.
Coffey DS; Smolev J; Heston WD; Scott WW
Natl Cancer Inst Monogr; 1978 Dec; (49):289-91. PubMed ID: 748782
[TBL] [Abstract][Full Text] [Related]
36. Growth inhibition by diethylstilbestrol and relapse of the Noble rat prostatic tumor.
Wakisaka M; Drury RE; Kadohama N
Hinyokika Kiyo; 1988 Jan; 34(1):107-15. PubMed ID: 3376790
[TBL] [Abstract][Full Text] [Related]
37. Androgen stimulated chemotherapy in the Dunning R-3327 prostatic adenocarcinoma.
Grossman HB; Kleinert EL; Lesser ML; Herr HW; Whitmore WF
Urol Res; 1981; 9(5):237-40. PubMed ID: 7303347
[TBL] [Abstract][Full Text] [Related]
38. Effect of zindoxifene on experimental prostatic tumours of the rat.
Schneider MR; Schiller CD; Humm A; von Angerer E
J Cancer Res Clin Oncol; 1991; 117(1):33-6. PubMed ID: 1997466
[TBL] [Abstract][Full Text] [Related]
39. Sustained in vivo regression of Dunning H rat prostate cancers treated with combinations of androgen ablation and Trk tyrosine kinase inhibitors, CEP-751 (KT-6587) or CEP-701 (KT-5555).
George DJ; Dionne CA; Jani J; Angeles T; Murakata C; Lamb J; Isaacs JT
Cancer Res; 1999 May; 59(10):2395-401. PubMed ID: 10344749
[TBL] [Abstract][Full Text] [Related]
40. Effect of medroxyprogesterone acetate, alone or in combination with epirubicin hydrochloride, on the growth of the Dunning R3327H prostatic adenocarcinoma.
Landström M; Tomić R; Damber JE
Eur Urol; 1987; 13(3):203-6. PubMed ID: 2956111
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
